PARIS, Dec 20 (Reuters) - France’s competition authority said on Wednesday it had fined U.S. healthcare group Johnson & Johnson 25 million euros ($29.62 million) relating to a case involving the pain killer product durogesic.
Durogesic is sold as a skin patch to control on-going moderate to severe pain. Because it contains opioid fentanyl, misusage can lead to death by overdose.
Officials at Johnson & Johnson could not be immediately reached for comment.
$1 = 0.8440 euros Reporting by Matthias Blamont; Writing by Sudip Kar-Gupta; Editing by Dominique Vidalon